Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers

Trial Profile

Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Feb 2017

At a glance

  • Drugs Exenatide (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors PegBio
  • Most Recent Events

    • 13 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 09 Jun 2015 Status changed from recruiting to active, no longer recruiting as results presented at the 75th Annual Scientific Sessions of the American Diabetes Association
    • 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top